CLINICAL_TRIALS
trial_result
· 2019-05-14
Clinical Trial Update: Triple III Comparison of Leflunomide Alone Versus Two DMARD Combinations in the Treatment of Rheumatoid Arthritis [Phase 3]
Summary
Phase 3 trial comparing leflunomide alone versus two DMARD combinations for rheumatoid arthritis has completed with results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: University of Nebraska | Conditions: Rheumatoid Arthritis | Phase 3 | Status: COMPLETED | Results posted: 2019-05-14